ugg boot discount Lateral Flow Technology And The Future Of Point Of Care Diagnostics
This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point of care testing, looking at both self testing by patients and at point of care testing by healthcare professionals.
Lateral flow devices and tests have been a popular platform for rapid immunoassays since their introduction in the mid 1980s, and since our last look at the market there has been continued interest and innovations. This report profiles over a hundred companies that currently market lateral flow tests. Many of these companies, plus more than ten additional companies, are developing innovations in lateral flow based devices. Companies profiled in this report use lateral flow technology to develop and market a wide range of rapid tests for market segments of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
Every critical aspect of the lateral flow test market is addressed, including the following key topics: The current sales figures for LF productsand realistic projections for 2017 The core factors driving LF testing revenues up. Breakout of LF POC market by Self Test and Professional Breakout of LF POC market by Key Test Segments (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other) The trends to watch that could increase sales predictions. Need to know companies in Lateral Flow Test devices. Expected gains to be made by LF POC devices over lab based immunoassays across categories. Regional markets for lateral flow tests (US, Europe, Japan, ROW) Obstacles that could trap new entrants. Growth in lateral flow point of care testing is being fueled by many factors fueling growth of the point of care market as a whole. These include the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever growing group of people with chronic diseases such as cardiovascular diseases, cancer and other chronic conditions, and many other factors. AccuBioTech Co., Ltd. Accumed Biology (Shanghai) Co., Ltd. Artron Laboratories Inc. Atlas Link Biotech Co., Ltd. Augurix SA/Augurix Diagnostics Autobio Diagnostics Co., Ltd. AZOG, Inc. BD (Becton Dickinson)Recent Revenue History: Company Overview and POC Products: Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)Recent Revenue History: Company Overview and POC Products: Biocare Diagnostics Ltd. Blue Cross Biomedical Co., Ltd. BNTX Inc Boson Biotech Co., Ltd. Branan Medical Corporation BHLMANN Laboratories AG Calypte Biomedical CorporationRecent Revenue History Company Overview and POC Products Recent Revenue History Company Overview and POC Products Dr. (A Quest Diagnostics Company) Eurospital Spa Express Diagnostics International EY Laboratories, Inc. First Check Diagnostics Corp. (Subsidiary of Alere) First Diagnostic LLC GenBio Germaine Laboratories Healgen Scientific LLC Hema Diagnostic Systems, LLC (HDS) Hemosure, Inc. Hightop Biotech Co., Ltd. IDenta Corporation ImmunoMycologics, Inc. ImmunoScience, Inc. Immunostics, Inc InBios International, Inc. Instant Technologies, Inc. InTec Products, Inc. International ImmunoDiagnostics Jant Pharmacal Corporation Jei Daniel Biotech Corp. Labsystems Diagnostics Group (Formerly Ani Biotech Oy) Labtest LifeSign LLC Liming BioProducts Co., Ltd. MagnaBioSciences, LLC MAVAND Solutions GmbH Medisensor, Inc. Precheck Bio, Inc. Prestige Diagnostics Preventis GmbH Princeton Biomeditech Corporation Quidel CorporationRecent Revenue History Company Overview and POC Products RBiopharm AG Real World Diagnostics Redwood Toxicology Laboratory, Inc. ReLIA Diagnostics, Inc. RENESA UGRecent Revenue History Company Overview and POC Products Reszon Diagnostics International Sdn. Bhd. SA Scientific Savyon Diagnostics Screening Devices Canada, Inc. Sekisui Medical Co., Ltd. Serascience Sichuan Maker Biotechnology Co., Ltd. Standard Diagnostics (Part of Alere) SureScreen Diagnostics Syntron Bioresearch, Inc. Systagenix Wound Management TECHLAB, Inc. Teco Diagnostics Theradiag Trinity Biotech plcRecent Revenue History Company Overview and POC Products Turklab Medical Devices Inc. UCP Biosciences, Inc. US Diagnostics, Inc. WAMA Diagnostica Zhuhai Encode Medical Engineering Co., Ltd.
CHAPTER SEVEN: COMPANIES ENTERING LF POC/RAPID TEST MARKET OR LAUNCHING NOVEL TESTS Alverix, Inc. Arbor Vita Corporation Axxin BioAMD Ltd. BioMedomics Corgenix Medical Corporation Epinex Diagnostics, Inc. Genisphere, LLC GenPrime, Inc. Mesa Tech International, Inc. TwistDx, Ltd. Venaxis, Inc. (Formerly Aspen BioPharma, Inc.) LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY Table 11: Lateral Flow Rapid Test Sales, Worldwide, 2012 and 2017 CHAPTER THREE: TECHNICAL ISSUES AND INNOVATIONS FOR LATERAL FLOW DEVICES Table 31: Selected Companies with Saliva or OralFluid Collection Devices Table 32: Selected Companies With Readers for Lateral Flow Devices Table 33: Selected Companies Developing and/or Marketing Innovations in LFT Table 34: Selected Companies Using Lateral Flow in Molecular Diagnostics Table 35: Selected Companies Developing and/or Marketing POC Diagnostic Platforms that May Compete with Lateral Flow Immunoassays
CHAPTER FOUR: ISSUES AND TRENDS Table 41: Selected Companies Outside of North America, Europe, or Japan Marketing Lateral Flow Diagnostic Tests
CHAPTER FIVE: MARKET ANALYSIS Table 51: Lateral Flow OTC/SelfTest Sales by Test Category, Worldwide, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other) Table 52: Lateral Flow Professional POC/Rapid Test Sales by Test Category, Worldwide, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other) Table 53: PointofCare Test Sales by Region, 2012 and 2017 (All POC Tests) Table 54: Worldwide POC/Rapid Test Sales by Test Category, 2012 and 2017 (Fertility, Infectious Disease, Cardiac Markers, Oncology, Drugs of Abuse, Other) Table 55: Selected Companies Marketing Fertility LFBased Tests Table 56: Selected Companies Marketing Infectious Disease LFBased Tests Table 57: Selected Companies Marketing LFBased Cardiac Marker Tests Table 58: Selected Companies Marketing LF Oncology LFBased Tests Table 59: Selected Companies Marketing Drugs of Abuse LFBased Tests Table 510: Selected Companies Marketing Other LFBased Tests.